The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.本發明係關於使用1,2,4－二唑苯甲酸化合物治療或預防與無義突變相關之疾病的特定劑量及服用方案。具體而言，本發明係關於在患有與無義突變相關之疾病的哺乳動物中使用3－[5－(2－氟－苯基)－[1,2,4]二唑－3－基]－苯甲酸之特定劑量及服用方案。
